Related references
Note: Only part of the references are listed.Severe Hemolytic Anemia Following Intravenous Immunoglobulin in an Infant With Kawasaki Disease
Vlad Tocan et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2017)
The Clinical Utility and Safety of a New Strategy for the Treatment of Refractory Kawasaki Disease
Takasuke Ebato et al.
JOURNAL OF PEDIATRICS (2017)
Association of hemolysis with high dose intravenous immunoglobulin therapy in pediatric patients: An open-label prospective trial
Alkim Oden Akman et al.
TRANSFUSION AND APHERESIS SCIENCE (2017)
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease A Scientific Statement for Health Professionals From the American Heart Association
Brian W. McCrindle et al.
CIRCULATION (2017)
Hepcidin-Induced Iron Deficiency Is Related to Transient Anemia and Hypoferremia in Kawasaki Disease Patients
Ying-Hsien Huang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Relationship between T-cell HLA-DR expression and intravenous immunoglobulin treatment response in Kawasaki disease
Hiroyuki Wakiguchi et al.
PEDIATRIC RESEARCH (2015)
Macrophage activation syndrome in Kawasaki Disease: More common than we thought?
Wei Wang et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2015)
The role of inflammation in intravenous immune globulin-mediated hemolysis
Jacob Pendergrast et al.
TRANSFUSION (2015)
Possible mechanisms for intravenous immunoglobulin-associated hemolysis: clues obtained from review of clinical case reports
Ruth Padmore
TRANSFUSION (2015)
Intravenous immune globulin-related hemolysis: comparing two different methods for case assessment
Elaine Taylor et al.
TRANSFUSION (2015)
Intravenous immunoglobulin-related hemolysis in patients treated for Kawasaki disease
Naomi L. C. Luban et al.
TRANSFUSION (2015)
Complementary use of passive surveillance and Mini-Sentinel to better characterize hemolysis after immune globulin
Scott Winiecki et al.
TRANSFUSION (2015)
Hemolysis in patients with antibody deficiencies on immunoglobulin replacement treatment
Isabella Quinti et al.
TRANSFUSION (2015)
Hemolytic anemia following high dose intravenous immunoglobulin in patients with chronic neurological disorders
L. H. Markvardsen et al.
EUROPEAN JOURNAL OF NEUROLOGY (2014)
Inflammatory cytokines as predictors of resistance to intravenous immunoglobulin therapy in Kawasaki disease patients
Satoshi Sato et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2013)
Hemolytic anemia following intravenous immunoglobulin therapy in patients treated for Kawasaki disease: a report of 4 cases
Roberta Berard et al.
PEDIATRIC RHEUMATOLOGY (2012)
Pathogenesis and management of Kawasaki disease
Anne H. Rowley et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2010)
Marker of T-cell activation is elevated in refractory Kawasaki disease
Hiroyuki Suzuki et al.
PEDIATRICS INTERNATIONAL (2010)
A pediatric case series of acute hemolysis after administration of intravenous immunoglobulin
David J. Gordon et al.
AMERICAN JOURNAL OF HEMATOLOGY (2009)
Acute Hemolysis After High-Dose Intravenous Immunoglobulin Therapy in Highly HLA Sensitized Patients
Joseph Kahwaji et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support
Paul A. Harris et al.
JOURNAL OF BIOMEDICAL INFORMATICS (2009)
Hemolytic transfusion reactions after administration of intravenous immune (gamma) globulin: a case series analysis
Zohra Daw et al.
TRANSFUSION (2008)
Share Paper
